MRE as a Biomarker in Clinical Trials

About Resoundant

Resoundant commercializes Magnetic Resonance Elastography (MRE), a proprietary MRI-based technology that noninvasively measures tissue stiffness to diagnose and stage liver fibrosis. The company's FDA-cleared solution is positioned as a superior alternative to invasive liver biopsies and other elastography techniques like FibroScan. With its technology now integrated into thousands of global imaging sites and recently accepted into the FDA's Biomarker Qualification Program, Resoundant is expanding its role in both clinical diagnostics and pharmaceutical clinical trials for liver diseases like MASH.

Therapeutic Areas